Momenta Pharmaceuticals Inc Asset Turnover Ratio (MNTA), as of second quarter 2020, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Momenta Pharmaceuticals inc   (NASDAQ: MNTA)
 

Momenta Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Momenta Pharmaceuticals Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.04 in the second quarter (Jun 30 2020)

Within sector 45 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2020 compared to the preceding quarter from 3503 to 3549.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MNTA Asset Turnover Ratio (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter
Y / Y Asset Change 9.09 % 1.84 % 178.89 % 12.59 % 21.3 %
Y / Y Revenue Change 27.56 % 116.12 % -80.89 % -57.06 % -60.23 %
Asset Turnover Ratio (TTM) 0.04 0.04 0.03 0.12 0.14
MNTA's Total Ranking # 3549 # 3503 # 3518 # 3518 # 3518
Seq. Asset Change -7.99 % -61.64 % 272.7 % -17.08 % -14.1 %
Seq. Revenue Change -25.64 % 8.64 % 28.02 % 23.33 % 25.99 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 46
Healthcare Sector # 510
Overall Market # 3549

Asset Turnover Ratio Statistics
High Average Low
0.28 0.18 0.05
(Jun 30 2015)   (Dec 31 2019)




MNTA Company Profile • Back to MNTA Efficiency Comparisons • Compare MNTA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2020, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2020 Assets at quarter ending Jun 30 2020
Capforce Inc   0.16 $ 3.274  Millions$ 20.726  Millions
Xenon Pharmaceuticals Inc   0.16 $ 27.291  Millions$ 173.580  Millions
Quotient Limited  0.16 $ 33.411  Millions$ 213.018  Millions
Therapeutic Solutions International Inc   0.15 $ 0.050  Millions$ 0.327  Millions
Theravance Biopharma inc   0.15 $ 76.796  Millions$ 505.976  Millions
Personalis Inc   0.15 $ 22.831  Millions$ 153.596  Millions
Lexaria Bioscience Corp   0.15 $ 0.391  Millions$ 2.664  Millions
Dicerna Pharmaceuticals Inc   0.15 $ 89.591  Millions$ 611.215  Millions
Molecular Templates Inc   0.15 $ 20.865  Millions$ 142.629  Millions
Envista Holdings Corporation  0.14 $ 909.200  Millions$ 6,295.700  Millions
Exicure Inc   0.14 $ 14.030  Millions$ 97.679  Millions
Guardion Health Sciences Inc   0.14 $ 1.836  Millions$ 12.787  Millions
Oncternal Therapeutics Inc   0.14 $ 2.952  Millions$ 20.864  Millions
Novan Inc   0.14 $ 5.229  Millions$ 37.295  Millions
Ultragenyx Pharmaceutical Inc   0.14 $ 159.411  Millions$ 1,140.655  Millions
Vir Biotechnology Inc   0.14 $ 72.706  Millions$ 521.016  Millions
Intellia Therapeutics Inc   0.14 $ 50.731  Millions$ 371.624  Millions
Nutriband Inc   0.14 $ 0.306  Millions$ 2.259  Millions
Navidea Biopharmaceuticals Inc   0.13 $ 0.689  Millions$ 5.139  Millions
Bluebird Bio Inc   0.13 $ 239.660  Millions$ 1,814.134  Millions
Alnylam Pharmaceuticals Inc   0.13 $ 345.180  Millions$ 2,647.687  Millions
Royalty Pharma Plc  0.13 $ 511.250  Millions$ 3,925.145  Millions
Dermtech Inc   0.13 $ 5.765  Millions$ 44.714  Millions
Kyntra Bio Inc   0.13 $ 108.437  Millions$ 845.855  Millions
Blueprint Medicines Corporation  0.13 $ 101.448  Millions$ 794.175  Millions
Catheter Precision Inc   0.13 $ 5.572  Millions$ 43.769  Millions
Remedent Inc   0.13 $ 0.974  Millions$ 7.664  Millions
Regenxbio Inc   0.13 $ 60.678  Millions$ 480.205  Millions
Novavax inc   0.13 $ 50.238  Millions$ 399.516  Millions
Paratek Pharmaceuticals Inc   0.13 $ 30.147  Millions$ 241.160  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.